Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
4107943
Reference Type
Journal Article
Title
Point-of-care (POC) testing of lactate in the intensive care patient - Accuracy, reliability, and costs of different measurement systems (Retracted article. See vol. 55, pg. 903, 2011)
Author(s)
Boldt, J; Kumle, B; Suttner, S; Haisch, G
Year
2001
Is Peer Reviewed?
Yes
Journal
Acta Anaesthesiologica Scandinavica
ISSN:
0001-5172
EISSN:
1399-6576
Volume
45
Issue
2
Page Numbers
194-199
Language
English
PMID
11167165
DOI
10.1034/j.1399-6576.2001.450210.x
Web of Science Id
WOS:000166778100010
Relationship(s)
has retraction
4104005
Retraction: Early recovery, cognitive function and costs of a desflurane inhalational vs. a total intravenous anaesthesia regimen in long-term surgery
Abstract
Background: Point-of-care (POC) monitoring may facilitate diagnostic and therapeutic interventions in the critically ill. In a prospective study reliability and costs of two POC lactate testing devices were compared to the central laboratory lactate monitoring method.
Methods: From arterial whole blood and capillary blood samples of 40 intensive care unit (ICU) patients lactate concentrations were measured using either a battery-powered handheld lactate analyser (Accusport(R)) or a bench-top blood gas analyser (Chiron 865 series) and compared with lactate measured by the hospital's central laboratory ('reference' method). Measurements were carried out on the day of inclusion in the study ('baseline'), 8 h later, and in the morning of the 1st, 2nd, and 3rd days thereafter. Costs for blood lactate measurements were analysed for each method.
Results: A total of 197 lactate measurements were done with each system. Lactate measured from arterial blood using the Accusport(R) and the central laboratory showed excellent agreement (bias: -0.15 mmol/l; relative error: -2.74%). Lactate measured by the blood gas analyser had also excellent agreement with the reference method (bias: 0.09 mmol/l; relative error: 2.24%) and the hand-held device (bias: -0.24 mmol/l; relative error: -5.06%). Time from blood sampling to availability of data was significantly longer for the central laboratory (85+/-35 min [range: 45-168 min]) than for both POC systems (range: 1-10 [range: 45-168 min]) than for both POC systems (range: 1-10 min). Total cost for measuring blood lactate was lowest using the Accusport(R) device.
Conclusion: The trend towards miniaturizing laboratory monitoring devices will continue, resulting in greater flexibility of management of the critically ill. Blood lactate can rapidly, easily, accurately, and economically be measured at the bedside with the hand-held monitor apparatus Accusport(R) and the bench-top blood gas analyser.
Keywords
critically ill; point-of-care (POC); lactate; accuracy; costs; outcome; hypoperfusion
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity